X
Xiaodong Zheng
Researcher at Ehime University
Publications - 54
Citations - 1587
Xiaodong Zheng is an academic researcher from Ehime University. The author has contributed to research in topics: Cornea & Pseudoexfoliation syndrome. The author has an hindex of 22, co-authored 54 publications receiving 1405 citations. Previous affiliations of Xiaodong Zheng include LSU Health Sciences Center New Orleans & Louisiana State University.
Papers
More filters
Journal ArticleDOI
A new method for tear film stability analysis using videokeratography
Tomoko Goto,Xiaodong Zheng,Stephen D. Klyce,Hisashi Kataoka,Toshihiko Uno,Mike Karon,Yoshiyuki Tatematsu,Takeo Bessyo,Kazuo Tsubota,Yuichi Ohashi +9 more
TL;DR: This new videokeratography system is a noninvasive and objective method with increased sensitivity for tear film stability analysis and displayed a similar rate of specificity in comparison with SLE-BUT.
Journal ArticleDOI
Gender- and age-related differences in corneal topography.
TL;DR: Investigation of gender-and age-related differences in the corneal topography of a normal population found decreases in levels of sex hormones may play a role in gender-related changes in cornea structure with age.
Journal ArticleDOI
Marx Line: Fluorescein Staining Line on the Inner Lid as Indicator of Meibomian Gland Function
TL;DR: In this paper, the location of a fluorescein-stained line, the Marx line (ML), which runs along the inner eyelid, is correlated with meibomian gland function.
Journal ArticleDOI
Tear film stability analysis system: introducing a new application for videokeratography.
TL;DR: TSAS is a noninvasive and objective method with higher sensitivity for tear film stability analysis than SLE-BUT, and eyes that had abnormal TSAS evaluation tended to have higher risk of developing superficial punctuate keratitis and dry eye symptoms after LASIK, and their responses to treatment were slow.
Journal ArticleDOI
Lysostaphin is effective in treating methicillin-resistant Staphylococcus aureus endophthalmitis in the rabbit.
Joseph J. Dajcs,Brett A. Thibodeaux,Emma B.H. Hume,Xiaodong Zheng,Gregory D. Sloop,Richard J. O'Callaghan +5 more
TL;DR: Lysostaphin is effective in treating experimental endophthalmitis mediated by MRSA and a significant reduction in the CFU/ml vitreous at 24 hours postinfection was obtained.